Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | Bon Natural Life Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
08.04. | Bon Natural Life Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
14.03. | Bon Natural Life Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
23.02. | Bon Natural Life Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
09.02. | Bon Natural Life Ltd - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
13.12.23 | Bon Natural Life Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
12.12.23 | Bon Natural Life Limited Announces Major Breakthrough in Apple Polyphenol Technology, Set to Boost Fiscal 2024 Sales | 5 | GlobeNewswire (USA) | ||
05.12.23 | Bon Natural Life gets $45M contract for broccoli products | 2 | Seeking Alpha | ||
05.12.23 | Bon Natural Life Limited Announces $45 Million Broccoli Product Order with Beijing Huahai Keyuan | 1 | GlobeNewswire (USA) | ||
28.11.23 | Bon Natural Life Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
11.09.23 | Bon Natural Life Limited Announces Record First Half-Year Revenue and Net Income | 297 | GlobeNewswire (Europe) | XI'AN, China, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal... ► Artikel lesen | |
07.07.23 | Bon Natural Life Limited Receives NASDAQ Notification Regarding Independent Board Requirement | 613 | GlobeNewswire (Europe) | XI'AN, China, July 07, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ORPEA | 12,338 | -0,93 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
NANO-X IMAGING | 9,100 | 0,00 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
BUTTERFLY NETWORK | 0,707 | 0,00 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen | |
GOODRX | 6,960 | -0,14 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
JOINT CORP | 12,280 | -2,46 % | The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results | ||
CARMAT | 3,660 | 0,00 % | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | 2023 sales of €2.8 million, i.e. 17 Aeson® implants, including 11 in the last quarter
2024 sales forecast of around €14 million
Active exploration of financing options to extend... ► Artikel lesen | |
PROGYNY | 32,600 | +0,62 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen | |
HYPERFINE | 0,810 | 0,00 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
MIMEDX | 6,430 | -1,23 % | MiMedx Group, Inc: MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results | Net Sales Grew 17% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter Net Income was $53 million, Inclusive of a $40 million One-Time Non-Cash Tax Benefit Fourth Quarter... ► Artikel lesen | |
BIOMERICA | 0,713 | -1,25 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
ATRION | 394,00 | +4,79 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
ATRICURE | 23,050 | -0,52 % | AtriCure upgraded at Oppenheimer on valuation | ||
OUTSET MEDICAL | 2,550 | 0,00 % | Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis | ||
AMWELL | 0,531 | 0,00 % | Amwell Receives Continued Listing Standard Notice From NYSE | Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York... ► Artikel lesen | |
TALKSPACE | 3,070 | -2,23 % | Talkspace Announces Third Quarter 2023 Results | B2B payor revenue grew 132% year-over-year 3Q 2023 Operating expenses of $24.0 million, down 30% year-over-year Reduced Net Loss to $4.4 million and Adjusted EBITDA1 loss to $2.8 million, an improvement... ► Artikel lesen |